Relapsed Pediatric AML
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06626 | Axitinib | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB08865 | Crizotinib | 2 | Recruiting | 1 |
DB00987 | Cytarabine | 2 | Recruiting | 1 |
DB01254 | Dasatinib | 2 | Recruiting | 1 |
DB00694 | Daunorubicin | 2 | Completed | 1 |
DB00530 | Erlotinib | 2 | Recruiting | 1 |
DB00773 | Etoposide | 2 | Recruiting | 1 |
DB01590 | Everolimus | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB01181 | Ifosfamide | 2 | Recruiting | 1 |
DB00619 | Imatinib | 2 | Recruiting | 1 |
DB06589 | Pazopanib | 2 | Recruiting | 1 |
DB08877 | Ruxolitinib | 2 | Recruiting | 1 |
DB00398 | Sorafenib | 2 | Recruiting | 1 |
DB00072 | Trastuzumab | 2 | Recruiting | 1 |
DB05294 | Vandetanib | 2 | Recruiting | 1 |
DB08881 | Vemurafenib | 2 | Recruiting | 1 |
DB14568 | Ivosidenib | Not Available | Approved for Marketing | 1 |